In vitro reversal of cataract: A pilot study

Currently, surgical removal of the opaque lens is the only available treatment for clinically significant cataract. Modern techniques yield high rates of success in restoring visual function and improving quality of life. Nonetheless, this surgery is unattainable for a large portion of the world’s population, especially in under-developed countries where access to surgical ophthalmic care is currently limited. Moreover, in spite of the general high safety of well-established advanced techniques employed in modern cataract surgery, various intraoperative and postoperative complications may occur in approximately 5% of the patients. Thus, devising pharmacological treatment for cataract may help amend the global morbidity associated with this major public health concern.